Protech Home Medical Stock Forecast, Price & News

-0.11 (-5.07 %)
(As of 05/12/2021)
Today's Range
50-Day Range
52-Week Range
Volume739,133 shs
Average Volume445,429 shs
Market CapitalizationC$58.13 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PTQ News and Ratings via Email

Sign-up to receive the latest news and ratings for Protech Home Medical and its competitors with MarketBeat's FREE daily newsletter.

Protech Home Medical logo

About Protech Home Medical

Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Protech Home Medical (CVE:PTQ) Frequently Asked Questions

Is Protech Home Medical a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Protech Home Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Protech Home Medical stock.
View analyst ratings for Protech Home Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Protech Home Medical?

Wall Street analysts have given Protech Home Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Protech Home Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Protech Home Medical's stock been impacted by COVID-19?

Protech Home Medical's stock was trading at C$0.60 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PTQ shares have increased by 243.3% and is now trading at C$2.06.
View which stocks have been most impacted by COVID-19

What price target have analysts set for PTQ?

2 brokers have issued twelve-month target prices for Protech Home Medical's stock. Their forecasts range from C$2.50 to C$3.00. On average, they expect Protech Home Medical's share price to reach C$2.75 in the next year. This suggests a possible upside of 33.5% from the stock's current price.
View analysts' price targets for Protech Home Medical
or view top-rated stocks among Wall Street analysts.

Who are Protech Home Medical's key executives?

Protech Home Medical's management team includes the following people:
  • Mr. Gregory J. Crawford, Chairman, Pres & CEO
  • Mr. Hardik Mehta, Chief Financial Officer
  • Mr. Jerry Kirn, VP of Operations
  • Mr. Mark Miles, VP of Technology
  • Mr. William Todd Zehnder, Chief Strategy Officer & Investor Relations (Age 46)
  • Cole Stevens, VP of Corp. Devel.
  • Leslie Becker, Exec. VP of Bus. Devel.
  • Dr. William Dana Frazier, Chief Medical Officer (Age 63)
  • Mr. Thomas W. Roehrig, Exec. VP of Fin. (Age 55)
  • Mr. Robert Grossman, Corp. Sec. (Age 47)

Who are some of Protech Home Medical's key competitors?

What other stocks do shareholders of Protech Home Medical own?

What is Protech Home Medical's stock symbol?

Protech Home Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PTQ."

How do I buy shares of Protech Home Medical?

Shares of PTQ and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Protech Home Medical's stock price today?

One share of PTQ stock can currently be purchased for approximately C$2.06.

How much money does Protech Home Medical make?

Protech Home Medical has a market capitalization of C$58.13 million and generates C$82.22 million in revenue each year.

What is Protech Home Medical's official website?

The official website for Protech Home Medical is

How can I contact Protech Home Medical?

The company can be reached via phone at 859-300-6455.

This page was last updated on 8/2/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.